Lilly's Cyramza succeeds in late-stage liver cancer trial

(Reuters) - Eli Lilly and Co on Wednesday said its drug Cyramza being tested as a treatment for liver cancer patients, who did not respond to prior therapy, met the main goal in a late-stage trial.